胸腺肽联合抗生素治疗老年慢性支气管炎急性发作期的疗效观察  

Thymosin and antibiotic treatment of acute exacerbation of chronic bronchitis period of observation

作　　者：杨立新[1] 唐秀光[1] 陈林[1] 

机构地区：[1]广西壮族自治区江滨医院,530021

出　　处：《中国实用医药》2008年第27期41-42,共2页China Practical Medicine

摘　　要：目的探讨胸腺肽联合抗生素治疗老年慢性支气管炎急性发作期的疗效及其安全性。方法选取老年慢性支气管炎急性发作期患者60例,随机分为胸腺肽组30例和对照组30例,胸腺肽组给予胸腺肽80 mg静脉滴注,1次/d,5-7 d为一个疗程,2组均采用常规抗感染、化痰、止咳等对症支持治疗。结果胸腺肽组显效率为70.0%,对照组为43.3%,胸腺肽组总有效率为86.7%,对照组为66.6%,2组比较差异显著（P〈0.05）。结论胸腺肽联合抗生素治疗老年慢性支气管炎急性发作期疗效肯定。To explore thymosin and antibiotic treatment to acute exacerbation of chronic bronchitis view of the efficacy and safety. Methods Elderly patients with chronic bronchitis patients with acute exacerbation of 60 patients were randomly divided into thymosin group of 30 patients and the control group of 30 patients, were given thymosin 80 mg intravenous drip, one time perday, 5 to 7 days for a course of treatment, Both groups were using conventional anti-infective, phlegm, cough, and other symptomatic therapy. Results Thymosin for the group were 70. 0%, 43.3% for the control group, Thymosin group, the total efficiency of 86. 7%, 66. 6% for the control group, the difference between the two groups was significant （ P 〈 0. 05 ）. Conclusion Thymosin and antibiotic treatment of acute exacerbation of chronic bronchitis efficacy.

关 键 词：胸腺肽 老年慢性支气管炎 急性发作期 

分 类 号：R562.21[医药卫生—呼吸系统]